Lilly Endowment (LLY) reports multiple stock sales, May–June 2026

Rhea-AI Filing Summary

The filer submitted a Form 144 notice reporting proposed sales of Eli Lilly and Company common stock by Lilly Endowment Inc. and related holders. The excerpt lists multiple sale dates between 05/06/2026 and 06/26/2026 with individual share quantities and gross proceeds for each trade.

Key Figures

Sale on 05/13/2026: 256,365 shares Proceeds on 05/13/2026: $259,024,427.96 Sale on 05/21/2026: 290,980 shares +4 more

7 metrics

Sale on 05/13/2026 256,365 shares trade date 05/13/2026

Proceeds on 05/13/2026 $259,024,427.96 gross proceeds reported for 05/13/2026

Sale on 05/21/2026 290,980 shares trade date 05/21/2026

Proceeds on 05/21/2026 $301,996,706.49 gross proceeds reported for 05/21/2026

Sale on 06/26/2026 305,000 shares trade date 06/26/2026

Proceeds on 06/26/2026 $367,501,820 gross proceeds reported for 06/26/2026

Trust entry shares 38,400,000 J.K. Lilly Sr. Trust line in excerpt

Key Terms

Form 144, selling holder, gross proceeds

3 terms

Form 144 regulatory

"The filer submitted a Form 144 notice reporting proposed sales"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

selling holder financial

"Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208"

gross proceeds financial

"256,365 | 259024427.96 (dollar amounts listed per trade)"

The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/07/2026 - 03:02 PM Accepted by SEC EDGAR 07/07/2026 - 03:02 PM Learn about SEC filing dates

FAQ

What does the LLY Form 144 filing report?

The filing reports proposed sales of Eli Lilly common stock by affiliated holders. It lists trade dates, share quantities, and dollar amounts for each sale between 05/06/2026 and 06/26/2026 as shown in the excerpt.

How many shares were reported sold on 05/13/2026 in the excerpt?

The excerpt shows a sale of 256,365 shares on 05/13/2026 with gross proceeds of $259,024,427.96. Each row lists the date, share count, and corresponding dollar figure.

Who is the selling holder named in the filing excerpt?

The selling holder repeatedly named in the excerpt is Lilly Endowment Inc. with address at 2801 North Meridian Street, Indianapolis IN 46208. The excerpt attributes multiple trades to this entity.

Does the excerpt state total shares held or outstanding?

The excerpt includes a line showing 38,400,000 tied to the J.K. Lilly Sr. Trust entry but does not label an aggregate outstanding total or explicitly state which numbers are shares outstanding; context is limited to the rows shown.

What time span do the reported sales cover in this excerpt?

The listed trades in the excerpt span from 05/06/2026 through 06/26/2026, with multiple sale dates and transaction rows shown for that period.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Fidelity Capital Markets 640 Fifth Avenue New York NY 10019	310000	372018600	941741406	07/07/2026	NYSE, NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/10/1948	Gift	J.K. Lilly Sr. Trust		01/21/1937	38400000		N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	05/06/2026	15828	15754535.92
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	05/11/2026	262	260690
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	05/12/2026	27545	27420659.12
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	05/13/2026	256365	259024427.96
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	05/20/2026	14020	14427122.57
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	05/21/2026	290980	301996706.49
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	05/22/2026	291106	310388133.68
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	05/26/2026	7494	8036754.45
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	05/27/2026	1400	1507545.06
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	05/28/2026	286078	323679520.16
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	05/29/2026	205	231267.59
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	06/04/2026	19619	22215692.36
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eil Lilly and Company Common Stock	06/05/2026	4098	4731943.80
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	06/26/2026	305000	367501820

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)